Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 11 | 2025 | 490 | 3.540 |
Why?
|
| Time-to-Treatment | 4 | 2026 | 134 | 2.480 |
Why?
|
| Orchiopexy | 2 | 2026 | 12 | 1.900 |
Why?
|
| Cryptorchidism | 2 | 2026 | 20 | 1.890 |
Why?
|
| Appendicitis | 4 | 2022 | 84 | 1.570 |
Why?
|
| Bariatric Surgery | 2 | 2026 | 65 | 1.520 |
Why?
|
| Wounds, Penetrating | 2 | 2023 | 33 | 1.490 |
Why?
|
| Postoperative Complications | 5 | 2026 | 1322 | 1.410 |
Why?
|
| Child, Preschool | 13 | 2026 | 2061 | 1.400 |
Why?
|
| Thoracic Injuries | 2 | 2022 | 46 | 1.390 |
Why?
|
| Retrospective Studies | 21 | 2026 | 6865 | 1.360 |
Why?
|
| Child | 18 | 2026 | 4612 | 1.310 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 41 | 1.190 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 71 | 1.150 |
Why?
|
| Infant | 11 | 2026 | 1693 | 1.090 |
Why?
|
| Adolescent | 16 | 2026 | 6306 | 1.050 |
Why?
|
| Surgicenters | 1 | 2026 | 9 | 0.970 |
Why?
|
| Short Bowel Syndrome | 1 | 2026 | 6 | 0.960 |
Why?
|
| Mediastinal Emphysema | 1 | 2026 | 12 | 0.960 |
Why?
|
| Legislation, Drug | 1 | 2026 | 22 | 0.960 |
Why?
|
| Intestinal Absorption | 1 | 2026 | 32 | 0.950 |
Why?
|
| Fundoplication | 2 | 2025 | 26 | 0.940 |
Why?
|
| Metals, Rare Earth | 1 | 2025 | 7 | 0.920 |
Why?
|
| Magnets | 1 | 2025 | 9 | 0.920 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 50 | 0.910 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 17 | 0.900 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.900 |
Why?
|
| Peritonitis | 1 | 2025 | 43 | 0.900 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 47 | 0.880 |
Why?
|
| Foreign Bodies | 1 | 2025 | 55 | 0.870 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 93 | 0.870 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.860 |
Why?
|
| Health Services Needs and Demand | 1 | 2026 | 219 | 0.860 |
Why?
|
| Residence Characteristics | 1 | 2026 | 230 | 0.850 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2022 | 62 | 0.850 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2023 | 116 | 0.840 |
Why?
|
| Internship and Residency | 2 | 2024 | 805 | 0.800 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 53 | 0.790 |
Why?
|
| Wounds, Gunshot | 1 | 2023 | 48 | 0.770 |
Why?
|
| Hepatoblastoma | 1 | 2023 | 10 | 0.770 |
Why?
|
| Transportation of Patients | 1 | 2023 | 50 | 0.750 |
Why?
|
| Humans | 33 | 2026 | 65141 | 0.740 |
Why?
|
| Rib Fractures | 1 | 2022 | 23 | 0.730 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 27 | 0.720 |
Why?
|
| Interviews as Topic | 1 | 2024 | 533 | 0.720 |
Why?
|
| Craniocerebral Trauma | 1 | 2022 | 53 | 0.720 |
Why?
|
| Musa | 1 | 2021 | 6 | 0.710 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.710 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 8 | 0.710 |
Why?
|
| General Surgery | 1 | 2024 | 211 | 0.700 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 32 | 0.700 |
Why?
|
| Models, Biological | 1 | 2026 | 1192 | 0.660 |
Why?
|
| Male | 20 | 2026 | 31055 | 0.660 |
Why?
|
| Wounds and Injuries | 1 | 2023 | 250 | 0.650 |
Why?
|
| Phytotherapy | 2 | 2018 | 34 | 0.650 |
Why?
|
| Infant, Newborn | 6 | 2026 | 1422 | 0.650 |
Why?
|
| Gastric Bypass | 1 | 2021 | 69 | 0.640 |
Why?
|
| Critical Illness | 1 | 2023 | 330 | 0.640 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 309 | 0.620 |
Why?
|
| Emergency Medical Services | 1 | 2023 | 261 | 0.620 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 93 | 0.610 |
Why?
|
| Plant Extracts | 2 | 2018 | 130 | 0.590 |
Why?
|
| Patient Readmission | 1 | 2023 | 448 | 0.590 |
Why?
|
| Treatment Outcome | 12 | 2025 | 5790 | 0.590 |
Why?
|
| Appendix | 1 | 2018 | 17 | 0.570 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.560 |
Why?
|
| Neuroblastoma | 1 | 2018 | 54 | 0.540 |
Why?
|
| Obesity | 1 | 2026 | 1273 | 0.540 |
Why?
|
| Female | 19 | 2026 | 34030 | 0.500 |
Why?
|
| Ultrasonography | 1 | 2018 | 489 | 0.480 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 704 | 0.470 |
Why?
|
| Thoracoscopy | 2 | 2004 | 29 | 0.420 |
Why?
|
| Appendectomy | 3 | 2020 | 57 | 0.380 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 644 | 0.380 |
Why?
|
| Hemothorax | 2 | 2022 | 9 | 0.360 |
Why?
|
| Thoracotomy | 2 | 2022 | 47 | 0.360 |
Why?
|
| Massachusetts | 4 | 2026 | 2145 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 1656 | 0.350 |
Why?
|
| Sutures | 2 | 2016 | 39 | 0.330 |
Why?
|
| Length of Stay | 4 | 2022 | 827 | 0.310 |
Why?
|
| Young Adult | 4 | 2023 | 4812 | 0.280 |
Why?
|
| Laparoscopes | 1 | 2007 | 23 | 0.260 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.260 |
Why?
|
| Rhodiola | 2 | 2018 | 15 | 0.250 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 129 | 0.250 |
Why?
|
| Pandemics | 2 | 2022 | 675 | 0.240 |
Why?
|
| Adult | 6 | 2026 | 17358 | 0.240 |
Why?
|
| Time Factors | 2 | 2023 | 3762 | 0.240 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 23 | 0.230 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 22 | 0.230 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.230 |
Why?
|
| Cannabis | 1 | 2026 | 54 | 0.220 |
Why?
|
| Injury Severity Score | 2 | 2023 | 117 | 0.220 |
Why?
|
| Operative Time | 1 | 2025 | 93 | 0.220 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2022 | 127 | 0.220 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.210 |
Why?
|
| Esophageal Atresia | 1 | 2004 | 9 | 0.210 |
Why?
|
| Incidence | 2 | 2026 | 1419 | 0.210 |
Why?
|
| Esophagus | 1 | 2004 | 47 | 0.210 |
Why?
|
| Reoperation | 1 | 2025 | 301 | 0.210 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 130 | 0.210 |
Why?
|
| Personnel Selection | 1 | 2024 | 57 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2704 | 0.200 |
Why?
|
| Glucose | 1 | 2026 | 476 | 0.190 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 66 | 0.190 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 244 | 0.190 |
Why?
|
| Trauma Centers | 1 | 2023 | 130 | 0.180 |
Why?
|
| Ligation | 1 | 2022 | 37 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 2484 | 0.180 |
Why?
|
| Pylorus | 1 | 2021 | 8 | 0.180 |
Why?
|
| Prevalence | 1 | 2026 | 1445 | 0.180 |
Why?
|
| Laparotomy | 1 | 2022 | 54 | 0.180 |
Why?
|
| United States | 2 | 2026 | 8098 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 348 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2022 | 266 | 0.170 |
Why?
|
| Gastrectomy | 1 | 2021 | 39 | 0.170 |
Why?
|
| Disease Progression | 1 | 2025 | 1219 | 0.160 |
Why?
|
| Lung | 1 | 2004 | 964 | 0.140 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 9 | 0.140 |
Why?
|
| Cytotoxins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2022 | 443 | 0.140 |
Why?
|
| Random Allocation | 2 | 2016 | 200 | 0.140 |
Why?
|
| Guinea Pigs | 1 | 2016 | 86 | 0.130 |
Why?
|
| Suture Techniques | 1 | 2017 | 94 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1149 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1036 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2763 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1566 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 587 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 414 | 0.120 |
Why?
|
| Wound Healing | 1 | 2016 | 193 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2293 | 0.110 |
Why?
|
| Pancreas | 1 | 2015 | 154 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 86 | 0.110 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.100 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2015 | 161 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 1016 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2017 | 727 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 318 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 298 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5614 | 0.090 |
Why?
|
| Animals | 4 | 2016 | 21333 | 0.070 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 14 | 0.060 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 7 | 0.060 |
Why?
|
| Dextrans | 1 | 2007 | 45 | 0.060 |
Why?
|
| Choristoma | 1 | 2007 | 24 | 0.060 |
Why?
|
| Intussusception | 1 | 2007 | 16 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 71 | 0.060 |
Why?
|
| Stomach | 1 | 2007 | 87 | 0.060 |
Why?
|
| Spermatic Cord Torsion | 1 | 2006 | 13 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2007 | 70 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 44 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 97 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 363 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 154 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2006 | 587 | 0.060 |
Why?
|
| Aged | 1 | 2021 | 14963 | 0.060 |
Why?
|
| Soft Tissue Infections | 1 | 2005 | 48 | 0.050 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 93 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2004 | 30 | 0.050 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 180 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 18273 | 0.050 |
Why?
|
| Pressure | 1 | 2004 | 78 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 118 | 0.050 |
Why?
|
| Models, Animal | 1 | 2004 | 241 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 394 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 26 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 456 | 0.050 |
Why?
|
| Gangrene | 1 | 2020 | 8 | 0.040 |
Why?
|
| Plant Roots | 1 | 2015 | 56 | 0.030 |
Why?
|
| Risk Factors | 1 | 2005 | 5430 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 610 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 930 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 896 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1270 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 882 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 524 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 367 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1698 | 0.020 |
Why?
|
| Bacteriuria | 1 | 2007 | 16 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 24 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 90 | 0.020 |
Why?
|
| Sheep | 1 | 2006 | 189 | 0.010 |
Why?
|
| Testis | 1 | 2006 | 160 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 657 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 319 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 203 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 801 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 3310 | 0.010 |
Why?
|